Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2

Ann Neurol. 1999 Aug;46(2):256-9. doi: 10.1002/1531-8249(199908)46:2<256::aid-ana17>3.0.co;2-6.

Abstract

Localized phosphorus (31P) and proton (1H) magnetic resonance spectroscopy was performed in the cerebellum and the occipital lobe of 6 patients with episodic ataxia type 2. From use of 31P magnetic resonance spectroscopy, untreated patients showed decreased high-energy phosphate ratios in the cerebrum, and increased pH in the cerebellum and cerebrum, which normalized under acetazolamide. 1H magnetic resonance spectra demonstrated high lactate peaks in 3 of the 6 patients. These metabolic alterations, probably induced by the calcium channelopathy, may characterize episodic ataxia type 2.

MeSH terms

  • Acetazolamide / therapeutic use*
  • Adult
  • Ataxia / drug therapy
  • Ataxia / metabolism*
  • Brain / metabolism*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Phosphorus
  • Protons

Substances

  • Protons
  • Phosphorus
  • Acetazolamide